A world wide team of researchers addressed one of the trickiest drugs to prescribe -- the blood-thinner warfarin. Each patient's optimal dose varies widely, is hard to predict, and is crucial for his ...
In a large-scale study and an upcoming clinical trial, scientists supported by the National Institutes of Health address one of the trickiest issues in prescribing medicine—how to quickly optimize ...
Atlanta, GA - In response to a lab error which led to an incorrect warfarin (Coumadin® - DuPont Pharmaceuticals) dosage, causing two deaths at a Philadelphia ...
Several reports suggested that using such genetic information may improve the initial estimate of what is a reasonable warfarin dose for individual patients. For example, mutations of VKORC1 make it ...
Digoxin was shown to be dangerous at high levels for atrial fibrillation (Afib) patients in a randomized trial. Meanwhile, another study suggested the benefit of genotyping for better warfarin ...
A new study published in the New England Journal of Medicine finds that a genetic test can help doctors effectively establish the proper dosage of warfarin, commonly referred by the brand name ...
Warfarin, a vitamin K antagonist, is the only oral anticoagulant available for use in the United States despite its narrow therapeutic range, considerable variability in dose response among patients, ...
Plasma Services Group (PSG) is a medical research company that recruits people with coagulation and clotting disorders to donate blood samples and plasma for diagnostic research. If you are actively ...
Warfarin is an alternative blood vessel. Warfarin is used to treat heart attacks, coumadin 3mg price, and coumadin 3mg price clots in veins and drawbacks. Coumadin can also be difficult to treat or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results